Chemo-Pharma (CPL) | Stock Overview & Key Data
Chemo-Pharma Performance Comparison
Stock Range
Today's Range
Low: ₹67.30
High: ₹68.54
on September 9, 2025
52 Week Range
Low: ₹66.00
High: ₹128.00
on August 26, 2025
on January 10, 2025
All-Time High: ₹128.00 on January 6, 2025
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR4.1B
EPS
5.66
P/E Ratio (TTM)
11.95
Forward P/E
N/A
P/B Ratio
2.52
PEG Ratio
0.61
Div. Yield
N/A
ROE
20.97%
Beta
0.230
Debt to Equity
44.70
Financial Highlights
Profitability
Gross Margin
29.30%
Operating Margin
9.62%
Profit Margin
11.11%
Returns and Earnings
Return on Assets (TTM)
11.26%
Return on Equity (TTM)
20.97%
EBITDA
INR367.0M
Net Income (TTM)
INR324.2M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR50.69
Quarterly Revenue Growth (YoY)
7.50%
Quarterly Earnings Growth (YoY)
34.20%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Chemo-Pharma CPL | 4.05B Small-cap | 1.22% | -10.60% | -11.27% | -19.24% | -41.64% | -10.86% | 284.53% | 120.36% |
| Ashok Leyland ASHOKLEY | 768.56B Large-cap | 7.33% | 19.05% | 13.01% | 32.90% | 23.34% | 11.15% | 70.17% | 242.56% |
| Escorts Kubota ESCORTS | 414.42B Large-cap | 3.52% | 12.55% | 14.72% | 28.67% | 14.33% | -1.06% | 95.47% | 204.56% |
| Vst Tillers Tractors VSTTILLERS | 45.44B Small-cap | -1.78% | 20.03% | 40.30% | 67.79% | 1.39% | 23.90% | 117.72% | 187.91% |
| Uniparts India UNIPARTS | 18.57B Small-cap | 3.77% | 21.80% | 10.72% | 29.70% | 0.04% | -15.90% | 254.03% | 252.82% |
| Indo Farm Equipment INDOFARM | 11.84B Small-cap | 8.57% | 22.63% | 54.36% | 42.43% | -6.38% | 1.22% | 1.22% | 1.22% |
Ownership & Short Interest
Insider Ownership
70.05%
Institutional Ownership
0.00%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
33K
Average 90-Day Volume
34K
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is CPL's 52-week high and low?
- In the last 52 weeks, Chemo-Pharma reached a high of ₹128.00 (on January 10, 2025) and a low of ₹66.00 (on August 26, 2025).
- What is the market cap and P/E ratio for CPL?
- Curious about Chemo-Pharma's size and valuation? Its market capitalization stands at 4.05B. When it comes to valuation, the P/E ratio (trailing twelve months) is 11.95, and the forward P/E (looking ahead) is N/A.
- Does CPL pay dividends? If so, what's the yield?
- As for dividends, Chemo-Pharma isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Chemo-Pharma's main competitors or similar companies to consider before investing?
When looking at Chemo-Pharma, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Ashok Leyland
ASHOKLEY768.56B Industrials Farm & Heavy Construction Machinery 11.15% 70.17% Escorts Kubota
ESCORTS414.42B Industrials Farm & Heavy Construction Machinery -1.06% 95.47% Vst Tillers Tractors
VSTTILLERS45.44B Industrials Farm & Heavy Construction Machinery 23.90% 117.72% Uniparts India
UNIPARTS18.57B Industrials Farm & Heavy Construction Machinery -15.90% 254.03% Indo Farm Equipment
INDOFARM11.84B Industrials Farm & Heavy Construction Machinery 1.22% 1.22% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Chemo-Pharma Laboratories Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Chemo-Pharma's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 20.97%, the Debt to Equity ratio from the most recent quarter is 44.70, and its Gross Profit Margin stands at 29.30%.
- What is the recent revenue and earnings growth for CPL?
- Looking at Chemo-Pharma's growth, its revenue over the trailing twelve months (TTM) was INR3B. Compared to the same quarter last year (YoY), quarterly revenue grew by 7.50%, and quarterly earnings saw a YoY growth of 34.20%.
- How much of CPL stock is held by insiders and institutions?
- Wondering who owns Chemo-Pharma stock? Company insiders (like executives and directors) hold about 70.05% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 0.00%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.